151 related articles for article (PubMed ID: 17653788)
1. Correlation of MRCP quantification (MRCPQ) with conventional non-invasive pancreatic exocrine function tests.
Gillams A; Pereira S; Webster G; Lees W
Abdom Imaging; 2008; 33(4):469-73. PubMed ID: 17653788
[TBL] [Abstract][Full Text] [Related]
2. Quantitative secretin MRCP (MRCPQ): results in 215 patients with known or suspected pancreatic pathology.
Gillams AR; Lees WR
Eur Radiol; 2007 Nov; 17(11):2984-90. PubMed ID: 17619882
[TBL] [Abstract][Full Text] [Related]
3. Quantitative MRCP assessment of pancreatic exocrine reserve and its correlation with faecal elastase-1 in patients with chronic pancreatitis.
Manfredi R; Perandini S; Mantovani W; Frulloni L; Faccioli N; Pozzi Mucelli R
Radiol Med; 2012 Mar; 117(2):282-92. PubMed ID: 22231574
[TBL] [Abstract][Full Text] [Related]
4. Suspected chronic pancreatitis with normal MRCP: findings on MRI in correlation with secretin MRCP.
Balci NC; Alkaade S; Magas L; Momtahen AJ; Burton FR
J Magn Reson Imaging; 2008 Jan; 27(1):125-31. PubMed ID: 18058927
[TBL] [Abstract][Full Text] [Related]
5. Normal pancreatic exocrine function does not exclude MRI/MRCP chronic pancreatitis findings.
Alkaade S; Cem Balci N; Momtahen AJ; Burton F
J Clin Gastroenterol; 2008 Sep; 42(8):950-5. PubMed ID: 18645530
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging and magnetic resonance cholangiopancreatography findings compared with fecal elastase 1 measurement for the diagnosis of chronic pancreatitis.
Bilgin M; Bilgin S; Balci NC; Momtahen AJ; Bilgin Y; Klör HU; Rau WS
Pancreas; 2008 Jan; 36(1):e33-9. PubMed ID: 18192870
[TBL] [Abstract][Full Text] [Related]
7. Exocrine pancreatic function assessed by secretin cholangio-Wirsung magnetic resonance imaging.
Calculli L; Pezzilli R; Fiscaletti M; Casadei R; Brindisi C; Gavelli G
Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):192-5. PubMed ID: 18397857
[TBL] [Abstract][Full Text] [Related]
8. Does secretin-stimulated MRCP predict exocrine pancreatic insufficiency?: A comparison with noninvasive exocrine pancreatic function tests.
Schneider AR; Hammerstingl R; Heller M; Povse N; Murzynski L; Vogl TJ; Caspary WF; Stein J
J Clin Gastroenterol; 2006 Oct; 40(9):851-5. PubMed ID: 17016144
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance hydrometry: non-invasive quantification of the exocrine pancreatic function.
Heverhagen JT; Battmann A; Kirsch M; Boehm D; Eissele R; Klose KJ; Wagner HJ
Rofo; 2002 Mar; 174(3):291-6. PubMed ID: 11885005
[TBL] [Abstract][Full Text] [Related]
10. Quantification of pancreatic exocrine function of chronic pancreatitis with secretin-enhanced MRCP.
Bian Y; Wang L; Chen C; Lu JP; Fan JB; Chen SY; Zhao BH
World J Gastroenterol; 2013 Nov; 19(41):7177-82. PubMed ID: 24222963
[TBL] [Abstract][Full Text] [Related]
11. MRI and MRCP findings of the pancreas in patients with diabetes mellitus: compared analysis with pancreatic exocrine function determined by fecal elastase 1.
Bilgin M; Balci NC; Momtahen AJ; Bilgin Y; Klör HU; Rau WS
J Clin Gastroenterol; 2009 Feb; 43(2):165-70. PubMed ID: 18797409
[TBL] [Abstract][Full Text] [Related]
12. Value of magnetic resonance cholangiopancreatography with secretin stimulation in the evaluation of pancreatic exocrine function after pancreaticogastrostomy.
Shinchi H; Takao S; Maemura K; Fukukura Y; Noma H; Matsuo Y; Mataki Y; Mori S; Iino S; Ehi K; Aikou T
J Hepatobiliary Pancreat Surg; 2004; 11(1):50-5. PubMed ID: 15754047
[TBL] [Abstract][Full Text] [Related]
13. Secretin-stimulated magnetic resonance cholangiopancreatography of patients with unclear disease in the pancreaticobiliary tract.
Hellund JC; Skattum J; Buanes T; Geitung JT
Acta Radiol; 2007 Mar; 48(2):135-41. PubMed ID: 17354131
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted MRI of the pancreas: correlation with secretin endoscopic pancreatic function test (ePFT).
Balci NC; Momtahen AJ; Akduman EI; Alkaade S; Bilgin M; Burton FR
Acad Radiol; 2008 Oct; 15(10):1264-8. PubMed ID: 18790398
[TBL] [Abstract][Full Text] [Related]
15. MR cholangiopancreatography at 3.0 T: intraindividual comparative study with MR cholangiopancreatography at 1.5 T for clinical patients.
Onishi H; Kim T; Hori M; Murakami T; Tatsumi M; Nakaya Y; Nakamoto A; Osuga K; Tomoda K; Nakamura H
Invest Radiol; 2009 Sep; 44(9):559-65. PubMed ID: 19692840
[TBL] [Abstract][Full Text] [Related]
16. Secretin-stimulated MRCP in volunteers: assessment of safety, duct visualization, and pancreatic exocrine function.
Mensel B; Messner P; Mayerle J; Fluhr G; Völzke H; Lerch MM; Ittermann T; Kühn JP
AJR Am J Roentgenol; 2014 Jan; 202(1):102-8. PubMed ID: 24370134
[TBL] [Abstract][Full Text] [Related]
17. Secretin-enhanced MRCP: review of technique and application with proposal for quantification of exocrine function.
Sanyal R; Stevens T; Novak E; Veniero JC
AJR Am J Roentgenol; 2012 Jan; 198(1):124-32. PubMed ID: 22194487
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic changes in patients with primary sclerosing cholangitis: MR cholangiopancreatography and MRI findings.
Ozkavukcu E; Erden A; Erden I
Eur J Radiol; 2009 Apr; 70(1):118-21. PubMed ID: 18282675
[TBL] [Abstract][Full Text] [Related]
19. [Fecal elastase-1 test: clinical evaluation of a new noninvasive pancreatic function test].
Takeda M; Shiratori K; Hayashi N; Odagiri E; Takasaki K
Rinsho Byori; 2002 Sep; 50(9):893-8. PubMed ID: 12386968
[TBL] [Abstract][Full Text] [Related]
20. Focal pancreatitis mimicking pancreatic mass: magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) findings including diffusion-weighted MRI.
Momtahen AJ; Balci NC; Alkaade S; Akduman EI; Burton FR
Acta Radiol; 2008 Jun; 49(5):490-7. PubMed ID: 18568532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
